Physician
GSL Hospital
GSL Hospital was paid $3.71M by Medicaid between Dec 2019 and Dec 2024, across 99 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
33Billing provider infoGSL HOSPITAL
ORWIGSBURG, PA 17961
ORWIGSBURG, PA 17961
33aNPI1265096069assigned 04/26/2019
33bProvider typeEmergency Medicine Physician
28Total paid$3.71M
24GClaims96,134
24DCodes billed99
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Pennsylvania
Rank by total paid#14 of 1,211
Median peer was paid$19K
This provider vs. median190×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 241 | $15K | |
| 2020 | 8,097 | $278K | |
| 2021 | 24,606 | $960K | |
| 2022 | 17,889 | $674K | |
| 2023 | 25,457 | $976K | |
| 2024incomplete | 19,844 | $802K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 8,656 | 8,331 | $1.05M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 11,590 | 11,221 | $985K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 2,473 | 2,371 | $398K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5.7% | 1,994 | 1,923 | $213K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.5% | 739 | 714 | $130K |
| G0378 | Hospital observation service, per hour | 3.0% | 120 | 111 | $112K |
| 80053 | Comprehensive metabolic panel | 2.7% | 9,658 | 9,209 | $98K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.3% | 1,225 | 1,143 | $84K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 1,677 | 1,624 | $68K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 11,732 | 11,163 | $63K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 1,388 | 1,356 | $47K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 4,515 | 4,275 | $45K |
87 more codes
| X0620 | 1.1% | 171 | $42K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 434 | $33K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 45 | $30K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 147 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 434 | $27K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 257 | $20K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,533 | $18K |
| 87631 | <1% | 99 | $16K | |
| 83605 | <1% | 2,089 | $14K | |
| 83690 | <1% | 3,077 | $14K | |
| 83880 | <1% | 448 | $13K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 182 | $11K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 763 | $10K |
| 84484 | <1% | 1,088 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,043 | $8K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 996 | $7K |
| 83735 | <1% | 1,066 | $7K | |
| 85730 | <1% | 1,144 | $7K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 88 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 407 | $6K |
| 81001 | <1% | 1,940 | $5K | |
| 85610 | <1% | 1,528 | $5K | |
| 73630 | <1% | 361 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 40 | $4K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 55 | $4K |
| 87070 | <1% | 465 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 158 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 155 | $3K |
| 73610 | <1% | 188 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,896 | $3K |
| 85379 | <1% | 304 | $3K | |
| 93971 | <1% | 43 | $3K | |
| 87040 | <1% | 130 | $2K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 27 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 267 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 46 | $2K |
| 81003 | <1% | 596 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 31 | $2K |
| 84703 | <1% | 124 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 701 | $1K |
| 73564 | <1% | 60 | $1K | |
| 82550 | <1% | 193 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 31 | $911.52 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $891.50 |
| 73030 | <1% | 55 | $711.79 | |
| 76000 | <1% | 55 | $650.17 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 17 | $645.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 27 | $575.70 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,717 | $555.93 |
| 72100 | <1% | 25 | $541.90 | |
| 80050 | General health panel | <1% | 13 | $526.68 |
| 84702 | <1% | 29 | $509.38 | |
| 85027 | <1% | 66 | $420.36 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 455 | $409.16 |
| 82948 | <1% | 215 | $378.89 | |
| 86140 | <1% | 152 | $348.03 | |
| 76642 | <1% | 12 | $337.32 | |
| 73502 | <1% | 14 | $252.32 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 640 | $248.34 |
| 73110 | <1% | 17 | $193.68 | |
| 73130 | <1% | 14 | $146.35 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,265 | $137.24 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,190 | $109.25 |
| 84100 | <1% | 15 | $106.51 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 85 | $100.00 |
| 82553 | <1% | 12 | $93.31 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 764 | $91.34 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 694 | $71.05 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 90 | $69.02 |
| 85652 | <1% | 13 | $36.24 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 71 | $11.26 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 213 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 12 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 24 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 39 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 31 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 569 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 36 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 587 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 13 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 127 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 35 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 17 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 40 | $0.00 |
| A9270 | Non-covered item or service | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHIAVAROLI, SUSAN (CVO SUPERVISOR)
| Provider | Location | Paid |
|---|---|---|
| ST. Luke's Physician Group, INC. | Tamaqua, PA | $516K |
| ST. Luke's Physician Group, INC. | Wind Gap, PA | $66K |
| GSLPG, INC | Orwigsburg, PA | $28K |
| ST. Luke's Physician Group, INC | Easton, PA | $24K |
| ST Luke's Physician Group INC | Bethlehem, PA | $17K |
| GSLPG Orthopedic Specialists | Orwigsburg, PA | $11K |
| ST. Luke's Physician Group, INC | Bethlehem, PA | $7K |
| GSLPG, INC | Orwigsburg, PA | $237.66 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.